155 related articles for article (PubMed ID: 10562705)
21. B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expression.
White CA; Nguyen KB; Pender MP
J Autoimmun; 2000 May; 14(3):195-204. PubMed ID: 10756081
[TBL] [Abstract][Full Text] [Related]
22. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
Shaw CM; Alvord EC
Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924
[No Abstract] [Full Text] [Related]
23. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice.
Engelhardt B; Kempe B; Merfeld-Clauss S; Laschinger M; Furie B; Wild MK; Vestweber D
J Immunol; 2005 Jul; 175(2):1267-75. PubMed ID: 16002731
[TBL] [Abstract][Full Text] [Related]
24. Role of Fas/FasL interaction in physiology and pathology: the good and the bad.
Sakata K; Sakata A; Kong L; Dang H; Talal N
Clin Immunol Immunopathol; 1998 Apr; 87(1):1-7. PubMed ID: 9576004
[No Abstract] [Full Text] [Related]
25. Astrocyte-induced T cell elimination is CD95 ligand dependent.
Bechmann I; Steiner B; Gimsa U; Mor G; Wolf S; Beyer M; Nitsch R; Zipp F
J Neuroimmunol; 2002 Nov; 132(1-2):60-5. PubMed ID: 12417434
[TBL] [Abstract][Full Text] [Related]
26. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis.
Vogt J; Paul F; Aktas O; Müller-Wielsch K; Dörr J; Dörr S; Bharathi BS; Glumm R; Schmitz C; Steinbusch H; Raine CS; Tsokos M; Nitsch R; Zipp F
Ann Neurol; 2009 Sep; 66(3):310-22. PubMed ID: 19798635
[TBL] [Abstract][Full Text] [Related]
27. The CD95(APO-1/Fas)/CD95L system.
Krammer PH
Toxicol Lett; 1998 Dec; 102-103():131-7. PubMed ID: 10022244
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
McCombe PA; Nickson I; Tabi Z; Pender MP
J Neurol Sci; 1996 Jul; 139(1):1-6. PubMed ID: 8836965
[TBL] [Abstract][Full Text] [Related]
29. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
30. C5b-9 complement complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
Rus H; Cudrici C; Niculescu F
Adv Exp Med Biol; 2006; 586():139-51. PubMed ID: 16893070
[No Abstract] [Full Text] [Related]
31. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
[TBL] [Abstract][Full Text] [Related]
32. The Fas counterattack: cancer as a site of immune privilege.
O'Connell J; Bennett MW; O'Sullivan GC; Collins JK; Shanahan F
Immunol Today; 1999 Jan; 20(1):46-52. PubMed ID: 10081230
[No Abstract] [Full Text] [Related]
33. Chronic remitting experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis.
Zapryanova E; Deleva D; Bakalska M; Filchev N
Neurosci Behav Physiol; 1999; 29(1):7-10. PubMed ID: 10088144
[No Abstract] [Full Text] [Related]
34. Fas system up-regulation in experimental autoimmune encephalomyelitis.
Ouallet J; Baumann N; Marie Y; Villarroya H
J Neurol Sci; 1999 Nov; 170(2):96-104. PubMed ID: 10561524
[TBL] [Abstract][Full Text] [Related]
35. Cell death in T- and B-cell development.
Debatin KM
Ann Hematol; 2001; 80 Suppl 3():B29-31. PubMed ID: 11757701
[No Abstract] [Full Text] [Related]
36. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
Raine CS
Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
[No Abstract] [Full Text] [Related]
37. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes.
Szabò I; Lepple-Wienhues A; Kaba KN; Zoratti M; Gulbins E; Lang F
Proc Natl Acad Sci U S A; 1998 May; 95(11):6169-74. PubMed ID: 9600936
[TBL] [Abstract][Full Text] [Related]
38. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition.
Bauer J; Bradl M; Hickley WF; Forss-Petter S; Breitschopf H; Linington C; Wekerle H; Lassmann H
Am J Pathol; 1998 Sep; 153(3):715-24. PubMed ID: 9736022
[TBL] [Abstract][Full Text] [Related]
39. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Yin LL; Lin LL; Zhang L; Li L
Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
[TBL] [Abstract][Full Text] [Related]
40. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.
Shriver LP; Dittel BN
Am J Pathol; 2006 Sep; 169(3):999-1011. PubMed ID: 16936273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
